Key Capital Coronavirus Treatment Advantage
10 mars 2020 09h30 HE
|
Key Capital Corporation
Key Capital’s KV-C19 Vaccine Candidate Offers Rapid, Effective And Cost-efficient Covid-19 Treatment Potential PHOENIX, AZ, March 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – KEY CAPITAL...